CBD May Improve Neurologic, Cognitive, QOL Outcomes in Sturge-Weber Syndrome
A small, prospective, open-label trial found evidence of improved quality of life (QOL) and clinical outcomes among patients with treatment-resistant Sturge-Weber syndrome when they were treated with CBD. Epidiolex (cannabidiol [CBD]) may hold promise for seizure control in treatment-resistant Sturge-Weber syndrome (SWS), according to a new study published in Pediatric ... Read More